Dandan Li

机构：China University of Geosciences (Beijing), Shandong Provincial Hospital, Shandong First Medical University · ORCID：0000-0001-9346-3212

发表论文 227 篇 · 总被引 5439 次 · h-index 38

代表论文

• TREM2 protects against LPS-induced murine acute lung injury through suppressing macrophage ferroptosis (2025 · International Immunopharmacology · 被引 14)
• Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial (2025 · Signal Transduction and Targeted Therapy · 被引 12)
• Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study (2025 · npj Precision Oncology · 被引 7)
• Natural Killer Cell Activation Signature Identifies Cyclin B1/CDK1 as a Druggable Target to Overcome Natural Killer Cell Dysfunction and Tumor Invasiveness in Melanoma (2025 · Pharmaceuticals · 被引 6)
• Addition of anti‐PD‐1 immunotherapy to BRAF inhibitor‐based targeted therapy improves real‐world survival and delays brain metastases in patients with BRAF V600 ‐mutant advanced melanoma: a multicenter cohort study (2025 · MedComm · 被引 5)
• Systematic evaluation of phenotypic variations induced by prophages in a clinical isolate of Pseudomonas aeruginosa (2025 · mSystems · 被引 3)